Involvement of CB1 cannabinoid receptors in emotional behaviour
- PMID: 11823890
- DOI: 10.1007/s00213-001-0946-5
Involvement of CB1 cannabinoid receptors in emotional behaviour
Abstract
Rationale: Endogenous and exogenous cannabinoids acting through the CB1 cannabinoid receptors are implicated in the control of a variety of behavioural and neuroendocrine functions, including emotional responses, and learning and memory processes. Recently, knockout mice deficient in the CB1 cannabinoid receptor have been generated, and these animals result in an excellent tool to evaluate the neurophysiology of the endogenous cannabinoid system.
Objectives: To establish the role of the CB1 cannabinoid receptor in several emotional-related behavioural responses, including aggressiveness, anxiety, depression and learning models, using CB1 knockout mice.
Methods: We evaluated the spontaneous responses of CB1 knockout mice and wild-type controls under different behavioural paradigms, including the light/dark box, the chronic unpredictable mild stress, the resident-intruder test and the active avoidance paradigm.
Results: Our findings showed that CB1 knockout mice presented an increase in the aggressive response measured in the resident-intruder test and an anxiogenic-like response in the light/dark box. Furthermore, a higher sensitivity to exhibit depressive-like responses in the chronic unpredictable mild stress procedure was observed in CB1 knockout mice, suggesting an increased susceptibility to develop an anhedonic state in these animals. Finally, CB1 knockout mice showed a significant increase in the conditioned responses produced in the active avoidance model, suggesting an improvement of learning and memory processes.
Conclusions: Taken together these findings demonstrate that endogenous cannabinoids through the activation of CB1 receptors are implicated in the control of emotional behaviour and participate in the physiological processes of learning and memory.
Similar articles
-
Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice.Eur J Neurosci. 2004 Apr;19(7):1906-12. doi: 10.1111/j.1460-9568.2004.03293.x. Eur J Neurosci. 2004. PMID: 15078564
-
Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission.Genes Brain Behav. 2009 Oct;8(7):685-98. doi: 10.1111/j.1601-183X.2009.00512.x. Epub 2009 May 28. Genes Brain Behav. 2009. PMID: 19563475
-
Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1.Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):462-6. doi: 10.1016/j.pnpbp.2007.09.018. Epub 2007 Sep 29. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 17980471
-
The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions.Behav Pharmacol. 2007 Sep;18(5-6):375-89. doi: 10.1097/FBP.0b013e3282d28fb4. Behav Pharmacol. 2007. PMID: 17762508 Review.
-
CB1 receptor-deficient mice as a model for depression.Neuroscience. 2012 Mar 1;204:193-206. doi: 10.1016/j.neuroscience.2011.09.031. Epub 2011 Sep 19. Neuroscience. 2012. PMID: 21964469 Review.
Cited by
-
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice.Pharmaceuticals (Basel). 2022 Apr 13;15(4):473. doi: 10.3390/ph15040473. Pharmaceuticals (Basel). 2022. PMID: 35455470 Free PMC article.
-
Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression.Cereb Cortex. 2019 Jul 5;29(7):2978-2997. doi: 10.1093/cercor/bhy164. Cereb Cortex. 2019. PMID: 30060068 Free PMC article.
-
The endocannabinoid system as an emerging _target of pharmacotherapy.Pharmacol Rev. 2006 Sep;58(3):389-462. doi: 10.1124/pr.58.3.2. Pharmacol Rev. 2006. PMID: 16968947 Free PMC article. Review.
-
Cannabinoid Receptors, Mental Pain and Suicidal Behavior: a Systematic Review.Curr Psychiatry Rep. 2018 Mar 15;20(3):19. doi: 10.1007/s11920-018-0880-4. Curr Psychiatry Rep. 2018. PMID: 29546501
-
Neuropsychiatric adverse effects of centrally acting antiobesity drugs.CNS Neurosci Ther. 2011 Oct;17(5):490-505. doi: 10.1111/j.1755-5949.2010.00172.x. Epub 2010 Jul 7. CNS Neurosci Ther. 2011. PMID: 21951371 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases